Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to ...

Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

Eli Lilly’s stock jumped 3.44% on May 12, ending the day at $759.83, and leaving investors mildly thrilled. This surge placed ...

Companies showing rapid sales growth and improving profit margins include Eli Lilly, Micron, AMD and Newmont Every quarter during earnings season it can be useful to see which companies have improved ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

Live Updates Live Coverage Has Ended What Sectors are Winning & Losing Today 11:28 am by Markets remain up today with the ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide. Trump said drug prices ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...